GoodRx Holdings Inc. (GDRX) PT Raised to $10 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts GDRX Hot Sheet
Price: $3.74 +7.16%
Rating Summary:
11 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
11 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Barclays analyst Stephanie Davis raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $10.00 (from $9.00) while maintaining a Overweight rating.
You May Also Be Interested In
- GoodRx to restate 2026 financials after Pharma Direct revenue error
- TETRA Technologies Inc. (TTI) PT Lowered to $11 at Stifel
- RxSight Inc. (RXST) PT Lowered to $5 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
